Breaking News Instant updates and real-time market news.

MET

MetLife

$52.06

-0.75 (-1.42%)

, JCI

Johnson Controls

$37.05

-1.46 (-3.79%)

10:27
11/10/17
11/10
10:27
11/10/17
10:27

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MetLife (MET) downgraded to Hold from Buy at Sandler O'Neill. 2. Johnson Controls (JCI) downgraded to Hold from Buy at Vertical Research with analyst Jeffery Sprague telling investors shares are "stuck in Purgatory." 3. Trovagene (TROV) downgraded to Hold from Buy at Maxim with analyst Jason Kolbert saying Trovagene needs to raise capital in order to gain a stronger position to transition to a therapeutics company focused on PCM-075. 4. Esterline (ESL) was downgraded to Hold from Buy at Drexel Hamilton and to Hold from Buy at SunTrust. 5. Marathon Oil (MRO) downgraded to Neutral from Buy at Citi with analyst Robert Morris citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MET

MetLife

$52.06

-0.75 (-1.42%)

JCI

Johnson Controls

$37.05

-1.46 (-3.79%)

TROV

Trovagene

ESL

Esterline

$71.75

-17.64 (-19.73%)

MRO

Marathon Oil

$15.58

-0.2 (-1.27%)

MET MetLife
$52.06

-0.75 (-1.42%)

11/10/17
SDLR
11/10/17
DOWNGRADE
SDLR
Hold
MetLife downgraded to Hold from Buy at Sandler O'Neill
10/18/17
GSCO
10/18/17
INITIATION
Target $61
GSCO
Conviction Buy
MetLife initiated with a Conviction Buy at Goldman Sachs
Goldman Sachs analyst Alex Scott started MetLife with a Conviction Buy and $61 price target while initiating coverage of the life insurance industry with a Neutral coverage view. The company's expense initiative will drive annual return on equity improvement for the next few years and the spinoff of Brighthouse will create a more stable earnings stream and book value, the analyst contends.
10/17/17
SBSH
10/17/17
UPGRADE
Target $123
SBSH
Buy
Prudential upgraded to Buy from Neutral at Citi
Citi analyst Suneet Kamath upgraded Prudential (PRU) to Buy and raised his price target for the shares to $123 from $110. The analyst also reiterates a Sell rating on MetLife (MET) with an unchanged price target of $47. Prudential's current valuation does not give the company enough credit for the quality of its business mix, Kamath tells investors in a research note. He believes the shares are attractive post the year-to-date underperformance. The analyst also thinks investors will be underwhelmed by Metlife's earnings growth and return on equity post the Brighthouse Financial (BHF) separation.
10/10/17
10/10/17
DOWNGRADE
Target $52

Neutral
MetLife downgraded to Neutral from Buy at FBR Capital
FBR Capital analyst Randy Binner downgraded MetLife (MET) to Neutral and lowered his price target for the shares to $52 from $53 ahead of the Q3 reporting season. Binner this morning also upgraded Prudential (PRU) to Buy.
JCI Johnson Controls
$37.05

-1.46 (-3.79%)

07/28/17
07/28/17
UPGRADE

Buy
Follow-up: Johnson Controls upgraded to Buy following pullback at Gabelli
As previously reported, Gabelli upgraded Johnson Controls to Buy from Hold. Analyst Brian Sponheimer said Johnson's Q3 report was disappointing but but said shares are trading at a discount and the Power Solutions business is underappreciated and is set up for an easy comp in FY18.
11/10/17
VERT
11/10/17
DOWNGRADE
VERT
Hold
Johnson Controls downgraded to Hold from Buy at Vertical Research
Vertical Research analyst Jeffery Sprague downgraded Johnson Controls to Neutral with a $40 price target telling investors shares are "stuck in Purgatory."
08/21/17
SBSH
08/21/17
NO CHANGE
SBSH
Buy
Johnson Controls accelerated CEO change a positive, says Citi
Citi analyst Andrew Kaplowitz said Johnson Controls' plan for George Oliver to take over the CEO post six months earlier than expected is a clear positive that removes the overhang of the company effectively having two CEOs - one in the role and one in waiting. Kaplowitz has a Buy rating on Johnson Controls shares.
08/07/17
MSCO
08/07/17
NO CHANGE
Target $46
MSCO
Overweight
Johnson Controls underperformance is unsustainable, says Morgan Stanley
Morgan Stanley analyst Nigel Coe said Johnson Controls' current underperformance is unsustainable and sees several catalysts over the next year to drive shares higher including a CEO change, Power divestiture, and free cash flow generation. Coe said shares are cheap and discount many issues, and sees so much value that can be unlocked. The analyst rates Johnson Controls an Overweight and lowered his price target to $46 from $51 to reflect a discounted valuation for Power Solutions.
TROV Trovagene

04/12/17
MAXM
04/12/17
UPGRADE
Target $4
MAXM
Buy
Maxim upgrades Trovagene back to Buy with $4 target
Maxim analyst Jason McCarthy upgraded Trovagene to Buy intraday after downgrading the stock to Hold on March 16. In-licensing a small molecule oncology drug from Nerviano Medical Sciences marks a new chapter for the company in precision cancer therapeutics, McCarthy tells investors in a research note. The analyst set a $4 price target for the shares. Trovagene in midday trading is up 15% to 87c.
04/12/17
MAXM
04/12/17
UPGRADE
Target $4
MAXM
Buy
Trovagene upgraded to Buy from Hold at Maxim
Maxim analyst Jason Kolbert upgraded Trovagene to Buy with a $4 price target. The analyst downgraded the shares to Hold on Marhc 16.
11/10/17
MAXM
11/10/17
DOWNGRADE
MAXM
Hold
Trovagene downgraded to Hold from Buy at Maxim
11/10/17
MAXM
11/10/17
DOWNGRADE
MAXM
Hold
Trovagene downgraded to Hold from Buy at Maxim
As reported earlier, Maxim analyst Jason Kolbert downgraded Trovagene to Hold from Buy and removed his $4 price target. Kolbert says the company closed Q3 with $7.4M in cash, which is likely to be much lower today. The analyst says Trovagene needs to raise capital in order to gain a stronger position to transition to a therapeutics company focused on PCM-075.
ESL Esterline
$71.75

-17.64 (-19.73%)

11/10/17
RHCO
11/10/17
DOWNGRADE
Target $77
RHCO
Hold
Esterline downgraded to Hold at SunTrust on downbeat FY18 outlook
As noted earlier, SunTrust analyst Michael Ciarmoli downgraded Esterline to Hold from Buy and lowered his price target to $77 from $105 following "bad" Q4 results and "even worse" outlook for FY18. The analyst says that he no longer expects the company to drive sustained margin expansion due to operational missteps, forecasting the stock price to retest the lows of the year. Ciarmoli adds that the mix headwinds in the Sensors and Systems segment could further deteriorate in FY19.
11/10/17
DRXL
11/10/17
DOWNGRADE
DRXL
Hold
Esterline downgraded to Hold from Buy at Drexel Hamilton
10/09/17
RBCM
10/09/17
NO CHANGE
Target $209
RBCM
Outperform
Defense and Aerospace sector poised for strong Q3, says RBC Capital
RBC Capital analyst Matthew McConnell previewed the Q3 earnings season for the defense and commercial aviation industries, raising price targets across the sectors. In defense, McConnell likes the companies with focus on international markets, where demand has not yet been reflected in orders or backlog. Among his favorites, McConnell raises the price target on Raytheon (RTN) to $209 from $193, General Dynamics (GD) to $241 from $220, Northrop Grumman (NOC) to $324 from $294, Lockheed Martin (LMT) to $327 from $289, and Triumph (TGI) to $38 from $33. He also states that there may be room for some consolidation in defense given that budget up-cycle is only 2 years old, profiling Astronics (ATRO), Barnes (B), Esterline (ESL), Heico (HEI), and Textron (TXT) as some of the potential targets. In commercial aviation, McConnell sees Boeing (BA) upside driven by continued strong air traffic growth, mature sales campaigns, and expectations for a strong wide-body replacement cycle starting in the early 2020s, raising his price target on Boeing to $269 from $235.
11/10/17
RHCO
11/10/17
DOWNGRADE
RHCO
Hold
Esterline downgraded to Hold from Buy at SunTrust
MRO Marathon Oil
$15.58

-0.2 (-1.27%)

07/12/17
07/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Marathon Oil (MRO) initiated with an Equal Weight at Stephens. 2. General Dynamics (GD) initiated with a Buy at Berenberg. 3. Brookfield Renewable (BEP) initiated with a Buy at TD Securities. 4. trivago (TRVG) initiated with a Market Perform at Wells Fargo. 5. Shopify (SHOP) initiated with a Hold at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/17
SOCG
11/02/17
UPGRADE
SOCG
Buy
Marathon Oil upgraded to Buy from Hold at Societe Generale
11/09/17
SBSH
11/09/17
DOWNGRADE
Target $14
SBSH
Neutral
Marathon Oil downgraded to Neutral from Buy at Citi
Citi analyst Robert Morris downgraded Marathon Oil to Neutral citing valuation and raised its price target to $16.50 from $14.00.
07/12/17
SPHN
07/12/17
INITIATION
Target $14
SPHN
Equal Weight
Marathon Oil initiated with an Equal Weight at Stephens
Stephens initiated Marathon Oil with an Equal Weight rating and $14 price target, saying that execution is now in focus with its asset base transformation complete.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.